Edges in Network
Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
Node | AKT2 |
Upstream (Parents) |
---|
(<<) ACTC1 → AKT2 |
(<<) ACTN4 → AKT2 |
(<<) CASP7 → AKT2 |
(<<) DNM2 → AKT2 |
(<<) DUSP10 → AKT2 |
(<<) KLF6 → AKT2 |
(<<) KLK10 → AKT2 |
(<<) LEMD1 → AKT2 |
(<<) MAL → AKT2 |
(<<) MAPK8 → AKT2 |
(<<) NFIX → AKT2 |
(<<) PLD3 → AKT2 |
(<<) PTAFR → AKT2 |
(<<) RAC1 → AKT2 |
(<<) RPS16 → AKT2 |
(<<) RRAS → AKT2 |
(<<) SERPINB5 → AKT2 |
(<<) SOX9 → AKT2 |
(<<) SPRR3 → AKT2 |
(<<) STK16 → AKT2 |
(<<) TPM2 → AKT2 |
(<<) YWHAH → AKT2 |
(<<) ZNF365 → AKT2 |
Downstream (Children) |
---|
AKT2 → APH1B (>>) |
AKT2 → CCNE1 (>>) |
AKT2 → CNFN (>>) |
AKT2 → ELK3 (>>) |
AKT2 → KCNG1 (>>) |
AKT2 → KRT14 (>>) |
AKT2 → KRT34 (>>) |
AKT2 → KYNU (>>) |
AKT2 → MREG (>>) |
AKT2 → NCOR2 (>>) |
AKT2 → PIK3R3 (>>) |
AKT2 → PLEK2 (>>) |
AKT2 → PRNP (>>) |
AKT2 → PYGL (>>) |
AKT2 → RARA (>>) |
AKT2 → SCARB1 (>>) |
AKT2 → TARS (>>) |
AKT2 → TFPI2 (>>) |